Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial

NCT02190357 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Changzheng Hospital